ConductScience.org, home

Paper884693

Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.

Pinedo HM and 1 other. Cancer Treat Rep, 1977. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity. Papers, record 884693. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/884693

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
3.96
iCite
Revised in PubMed
2014-11-20
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pinedo HMH M
2Chabner BAB A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell SurvivalMajor topic
MethotrexateMajor topic
Animals
Bone Marrow
Bone Marrow Cells
Cell Division
Cells, Cultured
DNA
Folic Acid
Humans
In Vitro Techniques
Osmolar Concentration
Purine Nucleosides
Time Factors

Source PubMed

Download CSV of topics

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
41824102Role of cystatin C in predicting the risk of hypermethotrexemia and kidney injury after high-dose methotrexate chemotherapy in childhood acute lymphoblastic leukemia.Ann Hematol2026https://conductscience.org/library/papers/41824102PubMed
41114001An In Vitro Platform for Pharmacokinetic Quantification and Optimization of Cerebrospinal Fluid Filtration and Drug Circulation.J Med Device2025https://conductscience.org/library/papers/41114001PubMed
40454410Cerebrospinal fluid attenuates the efficacy of methotrexate against acute lymphoblastic leukemia cells.Blood Neoplasia2025https://conductscience.org/library/papers/40454410PubMed
40258971An atlas of transcriptomic changes in human immune cells driven by 364 endogenous and gut-microbiota-derived metabolites.Sci Rep2025https://conductscience.org/library/papers/40258971PubMed
39527259Periprosthetic seromas and a third space effect after high-dose methotrexate.Wien Klin Wochenschr2025https://conductscience.org/library/papers/39527259PubMed
36688106Target concentration achievement for efficacy and safety of patients with osteosarcoma treated with high-dose methotrexate based on individual pharmacokinetics: A retrospective study.Oncol Lett2023https://conductscience.org/library/papers/36688106PubMed
34378331Prospective evaluation of high-dose methotrexate pharmacokinetics in adult patients with lymphoma using novel determinants of kidney function.Clin Transl Sci2022https://conductscience.org/library/papers/34378331PubMed
31657864Pharmacokinetic basis for dosing high-dose methotrexate in infants and young children with malignant brain tumours.Br J Clin Pharmacol2020https://conductscience.org/library/papers/31657864PubMed
29780646Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function.Case Rep Hematol2018https://conductscience.org/library/papers/29780646PubMed
21444869Shortening infusion time for high-dose methotrexate alters antileukemic effects: a randomized prospective clinical trial.J Clin Oncol2011https://conductscience.org/library/papers/21444869PubMed
16990760High leucovorin doses during high-dose methotrexate treatment may reduce the cure rate in childhood acute lymphoblastic leukemia.Leukemia2006https://conductscience.org/library/papers/16990760PubMed
15634030Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.Clin Pharmacokinet2005https://conductscience.org/library/papers/15634030PubMed
7160050
High-dose methotrexate: a clinical and pharmacokinetic evaluation. Treatment of advanced squamous cell carcinoma of the head and neck using a prospective mathematical model and pharmacokinetic surveillance.
Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7160050PubMed
6970753Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.J Clin Invest1981https://conductscience.org/library/papers/6970753PubMed
6585345Synchronization of human leukemic cells: relevance for high-resolution chromosome banding.Hum Genet1984https://conductscience.org/library/papers/6585345PubMed
3839754Clinical pharmacokinetics of 6-hour infusion of high-dose methotrexate. Preliminary trial of monitoring high infusion doses.Eur J Clin Pharmacol1985https://conductscience.org/library/papers/3839754PubMed
3733857Role of culture conditions and exposure duration in determining sensitivity of human bone marrow progenitor cells to methotrexate.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3733857PubMed
3555940Pharmacokinetics of anticancer drugs in children.Clin Pharmacokinet1987https://conductscience.org/library/papers/3555940PubMed
3311530Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.Clin Pharmacokinet1987https://conductscience.org/library/papers/3311530PubMed
3260832Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3260832PubMed

See all 25 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/884693

GET https://conductscience.org/api/papers/v1/884693/cited_by?page=2